Abstract
A malignant brain tumor diagnosis is often accompanied by intense feelings and can be associated with psychosocial conditions including depression, anxiety, and increased distress levels. Previous work has highlighted the impact of uncontrolled psychological distress among brain tumor patients. Given the negative impact of maladaptive psychosocial and biobehavioral factors on normal immune system functions, the question remains as to how psychological conditions potentially affect the brain tumor patient anti-tumor immune response. Since immunotherapy has yet to show efficacy at increasing malignant glioma patient survival in all randomized, phase III clinical trials to-date, this review provides new insights into the potential negative effects of chronic distress on brain tumor patient immune functions and outcomes.
Original language | English (US) |
---|---|
Pages (from-to) | 44-50 |
Number of pages | 7 |
Journal | Current Opinion in Behavioral Sciences |
Volume | 28 |
DOIs | |
State | Published - Aug 2019 |
Funding
This work was supported by NIH grants R00 NS082381 (D.A.W.), R01 NS097851-01 (D.A.W.), P50 CA221747 Project 2 (D.A.W. and R.V.L.), and T32 CA070085 (E.L.). This work was supported by NIH grants R00 NS082381 (D.A.W.), R01 NS097851-01 (D.A.W.), P50 CA221747 Project 2 (D.A.W. and R.V.L.), and T32 CA070085 (E.L.).
ASJC Scopus subject areas
- Psychiatry and Mental health
- Cognitive Neuroscience
- Behavioral Neuroscience